InvestorsHub Logo
Followers 22
Posts 2520
Boards Moderated 0
Alias Born 01/07/2015

Re: Karlchen post# 64

Friday, 01/01/2021 1:16:26 PM

Friday, January 01, 2021 1:16:26 PM

Post# of 130
I think the important thing is they have plenty cash now and the opportunity here imo is much more that this going to $1. LKYSF comments below from deal closing PR seems to indicate we can expect much more news in 2021.


In addition to the bought deal public offering, over the past 12 weeks, Numinus has received approximately $8.9 million in gross proceeds from the exercise of warrants and stock options.

"This over-subscribed financing, along with the exercised warrants and options, not only strengthens our cash position, but clearly demonstrates confidence in our business model, our progress, and our growth prospects," said Payton Nyquvest, Founder, CEO, and Chair, Numinus. "We are closing off 2020 in a strong position with the financing topping off our recent exclusive Psilocybe harvest and extraction, our planned compassionate access trial of psilocybin, our partnership with MAPS for an MDMA compassionate access trial, our national expansion with the acquisition of Mindspace, and our successful lobbying of Health Canada resulting in its notice of intent to amend the Special Access Programme to include accessibility to psilocybin and MDMA. We are ready for a fast-paced year ahead, and I would like to use this opportunity to sincerely thank our supporters and to wish you all a healthy, safe and happy New Year."